NAVITOR PHARMACEUTICALS, INC.
Profile
Company Names
NAVITOR PHARMACEUTICALS, INC.
CALORICS, INC.
Addresses
1030 MASSACHUSETTS AVENUE, SUITE 410, CAMBRIDGE, MA 02138
700 MAIN STREET, CAMBRIDGE, MA 02139
1000 WINTER STREET, SUITE 3350, WALTHAM, MA 02451
Phone Numbers
857-285-4300
781-538-6113
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
2010
State Incorporated:
DELAWARE
Total Amount Raised:
$68,208,337.00
Number of Funding Rounds:
5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2020-04-21
$20,186,771.00
$20,186,771.00
$0.00
Equity
4
2018-12-17
$11,250,003.00
$11,250,003.00
$0.00
Equity, Debt
3
2018-03-02
$11,250,002.00
$25,000,003.00
$13,750,001.00
Equity
2
2015-12-14
$12,000,001.00
$33,250,003.00
$21,250,002.00
Equity
1
2013-09-19
$13,521,560.00
$23,521,560.00
$10,000,000.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
KEVIN
BITTERMAN
DIRECTOR
PARASOL THERAPEUTICS INC
| TARIS BIOMEDICAL INC
| BIOLEX THERAPEUTICS, INC.
| FOLLICA, INC
| VISTERRA, INC.
| KALA PHARMACEUTICALS, INC.
| GENOCEA BIOSCIENCES, INC.
| NEURONETICS, INC.
| DIRECT VET MARKETING, INC.
| EDITAS MEDICINE, INC.
| MORPHIC HOLDING, LLC
| ATLAS VENTURE FUND XI, L.P.
| NAVITOR PHARMACEUTICALS, INC.
| AKERO THERAPEUTICS, INC.
| ATLAS VENTURE OPPORTUNITY FUND I, L.P.
| ATLAS VENTURE FUND XII, L.P.
| KINASET THERAPEUTICS, INC.
| ATLAS VENTURE OPPORTUNITY FUND II, L.P.
| ATLAS VENTURE FUND XIII, L.P.
| JUDO BIO INC.
| CHROMA MEDICINE, INC.
| REMIX THERAPEUTICS, INC.
| GRO BIOSCIENCES INC.
| ATLAS VENTURE FUND XIV, L.P.
| RENASANT BIO, INC.
| ATLAS VENTURE OPPORTUNITY FUND ILL, L.P.
ALAN
CRANE
DIRECTOR
CERULEAN PHARMA INC.
| PARASOL THERAPEUTICS INC
| SEVENTH SENSE BIOSYSTEMS, INC.
| T2 BIOSYSTEMS, INC.
| VISTERRA, INC.
| EXPERIMENT FUND, LLC
| OCULAR THERAPEUTIX, INC
| CALORICS, INC.
| XTUIT PHARMACEUTICALS, INC.
| NAVITOR PHARMACEUTICALS, INC.
| PANDION THERAPEUTICS, INC.
| SEISMIC THERAPEUTIC, INC.
JOHN
CREECY
DIRECTOR, EXECUTIVE OFFICER
RAJEEV
DADOO
DIRECTOR
SYNOVEX CORP
| ILLUMINOSS MEDICAL INC
| AVHANA HEALTH, INC.
| ADHERON THERAPEUTICS, INC.
| NAVITOR PHARMACEUTICALS, INC.
| PALLEON PHARMACEUTICALS INC.
| DREN BIO, INC.
| ARS PHARMACEUTICALS, INC.
| SR ONE CAPITAL FUND II-B, LP
| SR ONE CAPITAL FUND II-A, LP
| SR ONE CAPITAL FUND III, LP
| FORE US BIO INC.
JEAN-FRANCOIS
FORMELA
DIRECTOR
ARCA BIOPHARMA, INC.
| RESOLVYX PHARMACEUTICALS, INC.
| HORIZON PHARMA, INC.
| ANNOVATION BIOPHARMA, INC.
| ARTEAUS THERAPEUTICS, LLC
| COSTIM PHARMACEUTICALS INC.
| CALORICS, INC.
| NAVITOR PHARMACEUTICALS, INC.
| INTELLIA THERAPEUTICS, INC.
| IFM THERAPEUTICS, INC.
| SPERO THERAPEUTICS, LLC
| ATLAS VENTURE FUND XI, L.P.
| IFM TRE, INC.
| ATLAS VENTURE OPPORTUNITY FUND I, L.P.
| TRANSLATE BIO, INC.
| KORRO BIO, INC.
| IFM QUATTRO, INC.
| IFM CINQUE, INC.
| IFM CONTINUA, INC.
| ATLAS VENTURE FUND XII, L.P.
| SCORPION THERAPEUTICS, INC.
| SPERO THERAPEUTICS, INC.
| ATLAS VENTURE OPPORTUNITY FUND II, L.P.
| ATLAS VENTURE FUND XIII, L.P.
| AMAGMA, INC.
| IKENA ONCOLOGY, INC.
| ANTARES THERAPEUTICS, INC.
PAUL
FRIEDMAN
DIRECTOR
BRIAN
GALLAGHER
DIRECTOR
TRANSPORT PHARMACEUTICALS INC
| PROJECT MANAGEMENT HOLDINGS LTD
| SPRINGLEAF THERAPEUTICS, INC.
| RANA THERAPEUTICS, INC.
| CENTRAL IOWA LITHOTRIPSY, INC.
| RIVER VISION DEVELOPMENT CORP.
| COMMUNITY DEVELOPMENT TRUST INC
| CALCIMEDICA INC
| SPRINGBOT, INC.
| NAVITOR PHARMACEUTICALS, INC.
| RANA THERAPEUTICS, LLC
| TIER ONE HOLDING CORP.
| RANA THERAPEUTICS, INC.
| PACIFIC STREET FUND IV, L.P.
| SLATE BIO, INC.
THOMAS
HUGHES
EXECUTIVE OFFICER, DIRECTOR
DAVID
MADDEN
DIRECTOR
MARIAN
NAKADA
DIRECTOR
VINZENZ
PLOERER
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
